3rd Quarter - Report

W STRATEGIES, LLC for GLAXOSMITHKLINE

Period 3rd Quarter 2018 Filed Oct 16, 2018 Signed by Darren Willcox

Official filing
Firm
W STRATEGIES, LLC
Client
GLAXOSMITHKLINE
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.5333: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018. H.R.6378/S.2852: Reauthorization of PAHPA (Pandemic All-Hazards Preparedness Act).

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5333 (115th), S. 2852 (115th), H.R. 6378 (115th)

Budget/Appropriations BUD

H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision. H.R.1625: Consolidated Appropriations Act, 2018.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1892 (115th), H.R. 1625 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.